Clinical Trial Update: G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for RAEB-1,REAB-2 and AML Secondary to MDS Undergoing Allo-HSCT [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial compares G-CSF+DAC+BUCY versus G-CSF+DAC+BF conditioning regimens for RAEB-1/REAB-2 and AML secondary to MDS in patients undergoing allo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allogeneic Hematopoietic Stem Cell Transplantation
• Myelodysplastic Syndrome

Drugs mentioned

• BF (busulfan + fludarabine conditioning regimen)
• BUCY
• DAC
• G-CSF (granulocyte colony-stimulating factor)

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Myelodysplastic Syndrome, Allogeneic Hematopoietic Stem Cell Transplantation | Phase 2, Phase 3 | Status: UNKNOWN